Chegini, Nasser <br/><br/>
Expression of matrix metalloproteinase-26 and tissue inhibitor of matrix metalloproteinase-3 and -4 in endometrium throughout the normal menstrual cycle and alteration in users of levonorgestrel implants who experience irregular uterine bleeding.  [electronic resource] 

 -  Fertility and sterility  Sep 2003 
 - 564-70 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0015-0282 
<br/><br/><label>Standard No.: </label>10.1016/s0015-0282(03)00797-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Contraceptive Agents, Female--administration & dosage<br/>Drug Implants<br/>Endometrium--metabolism<br/>Female<br/>Humans<br/>Immunohistochemistry--methods<br/>Levonorgestrel--administration & dosage<br/>Matrix Metalloproteinases--metabolism<br/>Matrix Metalloproteinases, Secreted<br/>Menstrual Cycle--metabolism<br/>Prospective Studies<br/>Reference Values<br/>Staining and Labeling<br/>Tissue Inhibitor of Metalloproteinase-3--metabolism<br/>Tissue Inhibitor of Metalloproteinases--metabolism<br/>Uterine Hemorrhage--chemically induced<br/>Tissue Inhibitor of Metalloproteinase-4